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Summary The present study compared values of stroke volume estimated by bioreactance 
and magnetic resonance imaging, and assessed the relationship and agreement between the 
two methods. Twenty-five healthy subjects underwent non-invasive haemodynamic 
assessment by magnetic resonance imaging and bioreactance methods. Bioreactance 
produced 8% (6 ml/beat) higher stroke volume than magnetic resonance imaging (68 ± 11 vs. 
74 ± 15 ml/beat P < 0.01), with lower and upper limits of agreement of -9 and 19 ml/beat 
between the two methods. There was a strong relationship between the two methods (r = 0.82, 
P <0.01). Although the mean difference and relationship between the two methods are 
acceptable, the limits of agreement are wide suggesting the methods cannot be used 
interchangeably in clinical practice.      
Key words: Stroke volume, Magnetic resonance imaging, Bioreactance 
Introduction Monitoring of cardiac output has wide clinical application in surgery, 
anesthesiology, emergency care, and cardiology.1-8 The “gold standard” reference methods 
(i.e. Thermodilution and direct Fick remain) are invasive and are associated with inherent 
risks e.g. infections, arrhythmias and bleeding.9 Cardiac magnetic resonance imaging (MRI) 
has been suggested to be a non-invasive “gold standard” method,10 but its complexity and 
cost prevent its use in routine clinical practice. Bioreactance is a novel non-invasive, 
continuous monitoring method which estimates cardiac output by analysing the frequency of 
relative phase shift of electronic current applied across the thorax.11 12 Several studies 
demonstrated its clinical application and performance, 11-17 but its comparison with MRI has 
not been evaluated yet.  The present study aimed to i) compare values of stroke volume 
estimated by bioreactance and MRI methods, and ii) to assess the relationship and agreement 
between the two methods. 
  
Methods Twenty five healthy female individuals took part in the study (age 48 ± 18 years, 
range 25 – 78, height 1.63 ± 0.07m, weight 62.7 ± 10.2kg, body mass index 23.9 ± 4.4). In a 
cross-over design, each subject underwent measurements using cardiac MRI and bioreactance 
methods on consecutive days. All participants provided written informed consent. This study 
was approved by the Local Research Ethics Committee. Cardiac MRI was performed using a 
3T Philips Achieva and a 6-channel cardiac coil (both Philips, Best, NL), as previously 
described.18 The bioreactance method (NICOM, Cheetah Medical, Delaware, USA) was used 
to assess haemodynamic variables continuously during a 10 minute while subjects rested in a 
semi-recumbent position.16-19  The difference between MRI and bioreactance was assessed 
using a t-test. Pearson’s product moment coefficient of correlation was used to assess the 
relationship between MRI and bioreactance stroke volume values, Bland-Altman analysis 
performed to agreement. Statistical significance was indicated P < 0.05, and data presented as 
mean ± SD.  
Results and Discussion The mean difference between the MRI and bioractance stroke 
volumes was 6 ml/beat (68 ± 11 vs. 74 ± 15, P < 0.01), with bioreactance demonstrating on 
average 8% higher values than MRI. Pearson’s correlation coefficient revealed a strong 
positive correlation between the two methods (r = 0.84, P < 0.01; Figure 1).  In addition to 
the mean difference, Bland-Altman analysis also revealed lower and upper limits of 
agreement of -9 and 19 ml/beat respectively. This is the first study to compare the stroke 
volume obtained by bioreactance and cardiac MRI. A strong relationship between the stroke 
volume estimates of bioreactance and MRI, as well as a relatively small mean difference 
suggests that bioreactance could potentially be used in wider clinical practice where the use 
of gold standard, invasive- or non-invasive methods is not viable. This is particularly 
important in clinical settings where it is necessary to estimate haemodynamic response to a 
physiological or pharmacological challenges e.g. fluid responsiveness, passive leg raising, 
surgery, drug titration and anaesthesia. The present findings suggest that bioreactance cannot 
be used interchangeably with MRI. However, it should not preclude its use in clinical practice 
where its advantages over the gold-standard methods have been well documented, and its 
reliability in challenging hemodynamic scenarios confirmed.11-17   
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Figure 1. Relationship between magnetic resonance imaging and bioreactance stroke volume 
values.  
Figure 1 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
